Scientists at the University of Cambridge have achieved what was once considered impossible by electrically powering insulating nanoparticles to create a completely new kind of LED. Using tiny organic “molecular antennas,” the team found a way to funnel energy into materials that normally cannot conduct electricity, producing ultra pure near infrared light with remarkable efficiency.
Time might be even stranger than Einstein imagined. Physicists are now exploring the possibility that a single clock could exist in a quantum superposition, ticking both faster and slower at the same time — almost like Schrödinger’s cat being both alive and dead simultaneously. Using incredibly precise atomic clocks and cutting-edge quantum technologies, researchers believe they may soon be able to test this bizarre prediction in the lab for the first time.
Researchers have developed customizable omega-3 nanoemulsion drinks to protect astronauts’ bones and muscles from space radiation. [ https://www.labroots.com/trending/space/30563/tailored-drink…utrition-2](https://www.labroots.com/trending/space/30563/tailored-drink…utrition-2)
How could customizable drinks help provide astronauts on future, long-term space missions with the proper levels of nutrition? This is what a recent study published in ACS Food Science & Technology hopes to address as a team of researchers investigated novel methods for improving future astronaut diets. This study has the potential to help scientists, mission planners, and astronauts develop improved dietary plans, specifically as space mission durations are aimed to increase in the coming years.
For the study, the researchers introduced beverage nanoemulsion drinks, with emulsion drinks being a common drink that typically consists of a blended mixture of two normally non-mixable substances like an oily substance and watery substance with microscopic droplets within the liquid since they don’t full mix together. In this case, the researchers propose nanoemulsion drinks with even smaller droplets and consist of water and Omega-3 fatty acids (fish oil), which provide bone and muscle protection against space radiation.
In the end, the researchers found that customizable drinks with a variety of sweetness levels and flavors are the best options. Going forward, the researchers aspire to test the tastiness of the beverages under microgravity conditions, as they note the drinks taste like typical flat sodas after carbonation loss.
When researchers at Yale gave a shelved cancer drug to old mice whose brains were already riddled with Alzheimer’s-like damage, the animals started remembering again. Synapses that had gone quiet flickered back to life. Proteins that mark healthy brain connections climbed toward normal levels. And when the drug was taken away, the cognitive gains stuck.
The drug is saracatinib, originally developed by AstraZeneca under the code name AZD0530 to treat solid tumors. It never panned out for cancer. But a team led by Stephen Bhatt and Christopher van Dyck at Yale School of Medicine recognized that its molecular target, an enzyme called Fyn kinase, plays a central role in how amyloid-beta destroys synapses in Alzheimer’s disease. Their work, published across several peer-reviewed studies between 2015 and 2020, has made saracatinib one of the more closely watched examples of drug repurposing in neuroscience. As of mid-2026, the compound’s preclinical results remain striking, but its clinical story is more complicated.
The heart’s constant beating may actively suppress tumor growth in cardiac tissues, a new Science study reports. This is because cellular pathways in these tissues alter gene regulation in cancer cells to keep them from proliferating.
The findings shed light on the role of mechanical forces in protecting the heart from cancer and may pave the way to new cancer therapies based on mechanical stimulation.
The heart rarely develops cancer, and, at the same time, it lacks regenerative capacity, as cardiomyocytes stop proliferating after birth. This suggests that mechanisms limiting cardiac regeneration may also protect against cancer. In this work, we investigated the role of mechanical load and used in vivo cancer models and ex vivo engineered heart tissues to show that mechanical load reduces cancer cell proliferation in the myocardium. Spatial transcriptomics of human cardiac metastases revealed decreased histone methylation and chromatin compaction. These changes affect chromatin accessibility at proliferation-related loci, with Nesprin-2 identified as a key mechanosensor. Our results uncover how mechanical forces protect the heart from cancer and suggest potential strategies for cancer therapy based on mechanical stimulation.
What if every scientific paper you read was just the “highlight reel” of a much longer, messier, and more complicated movie? You see the breakthrough, but you never see the hundreds of hours of footage showing what didn’t work.
Ultimately, the ARA marks a shift toward a future where “The Last Human-Written Paper” isn’t the end of science, but the beginning of a much deeper, machine-readable conversation.
However, this shift toward radical transparency comes with its own set of hurdles. While ARAs make AI agents more efficient, the study found a “prior-run box” effect where seeing a human’s past failures actually limited an AI’s ability to think outside the box and find creative new solutions. There is also a significant cultural and technical gap to bridge: the system relies on researchers being willing to expose their “messy” unfinished work, and even with better data, the jump in actual experiment reproduction was relatively modest. Furthermore, the reliance on “compilers” to translate old papers into this new format risks baking in errors or “hallucinations” if the original source was vague, proving that while machine-readable data is powerful, it isn’t a magic fix for the inherent complexities of scientific discovery.
How animals detect Earth’s magnetic field remains a mystery in sensory biology. Despite extensive behavioral evidence, the neural circuitry and molecular mechanisms responsible for magnetic sensing remain elusive. Adopting an unbiased approach, we used whole-brain activity mapping, tissue clearing, and light sheet microscopy to identify neuronal populations activated by magnetic stimuli in the pigeon (Columba livia). We demonstrate robust, light-independent bilateral neuronal activation in the medial vestibular nuclei and the caudal mesopallium. Single-cell RNA sequencing of the semicircular canal cristae revealed specialized type II hair cells that express the molecular machinery necessary for the detection of magnetic stimuli by electromagnetic induction.
What if every scientific paper you read was just the “highlight reel” of a much longer, messier, and more complicated movie? You see the breakthrough, but you never see the hundreds of hours of footage showing what didn’t work.
Ultimately, the ARA marks a shift toward a future where “The Last Human-Written Paper” isn’t the end of science, but the beginning of a much deeper, machine-readable conversation.
However, this shift toward radical transparency comes with its own set of hurdles. While ARAs make AI agents more efficient, the study found a “prior-run box” effect where seeing a human’s past failures actually limited an AI’s ability to think outside the box and find creative new solutions. There is also a significant cultural and technical gap to bridge: the system relies on researchers being willing to expose their “messy” unfinished work, and even with better data, the jump in actual experiment reproduction was relatively modest. Furthermore, the reliance on “compilers” to translate old papers into this new format risks baking in errors or “hallucinations” if the original source was vague, proving that while machine-readable data is powerful, it isn’t a magic fix for the inherent complexities of scientific discovery.
We systematically evaluated the medical reasoning abilities of an LLM across six diverse experiments, comparing the model with hundreds of expert physicians. Overall, the model outperformed physicians across experiments, including in cases utilizing real and unstructured clinical data taken directly from the health record in an emergency department. These diagnostic touchpoints mirror the high-stakes decisions taken in emergency medicine departments, where nurses and clinicians make time-sensitive choices with limited information. Our results showed that humans, GPT-4o, and o1 all improved their diagnostic abilities as more information was available; o1 outperformed humans at multiple touchpoints, with the widest gap at initial ER triage, where there is the least information available.
The rapid pace of improvement in LLMs has substantial implications for the science and practice of clinical medicine. Although applying AI to assist with clinical decision support is sometimes viewed as a high-risk endeavor (22, 23), greater use of these tools might serve to mitigate the human and financial costs of diagnostic error, delay, and lack of access (24, 25). Our findings suggest the urgent need for prospective trials to evaluate these technologies in real-world patient care settings and for health care systems to prepare for investments for computing infrastructure and design for clinician-AI interaction that can facilitate the safe integration of AI tools into patient-care workflows. This includes the development of robust monitoring frameworks to oversee the broader implementation of AI clinical decision support systems (22), monitoring not just final diagnostic accuracy but other metrics crucial for successful deployment, including safety, efficiency, and cost.
We emphasize that our study addresses only text-based performance for both humans and machines; clinical medicine is multifaceted and awash with nontext inputs, including auditory (such as the patient’s level of distress) and visual information (for example, interpretation of medical imaging studies) that clinicians routinely use. Existing studies suggest that current foundation models are more limited in reasoning over nontext inputs (26, 27); future work is needed to assess how humans and machines may effectively collaborate (28) in use of nontext signals. This requires new benchmarks, trials, and technological solutions to more faithfully measure clinical encounters. Existing investment in increasingly pervasive ambient AI scribes and other passive monitoring technologies holds promise to serve as the basis for such investigations.